Profiles

Keywords
Last Name
Institution

Keith Millikan

Concepts (257)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hernia, Ventral
9
2018
24
2.290
Why?
Surgical Mesh
11
2014
30
2.070
Why?
Herniorrhaphy
9
2018
35
1.940
Why?
Hernia, Inguinal
7
2016
22
1.600
Why?
Postoperative Complications
20
2018
983
1.470
Why?
Obesity, Morbid
2
2017
70
1.380
Why?
Laparoscopy
13
2016
174
1.250
Why?
Adenocarcinoma
6
2016
228
1.220
Why?
Esophageal Neoplasms
7
2002
59
1.140
Why?
Stomach Neoplasms
3
2016
38
0.930
Why?
General Surgery
4
2015
56
0.810
Why?
Cholecystectomy, Laparoscopic
7
2015
36
0.740
Why?
Gastroplasty
1
2016
27
0.710
Why?
Clinical Clerkship
3
2013
27
0.690
Why?
Gastric Bypass
1
2016
52
0.670
Why?
Middle Aged
42
2018
10247
0.670
Why?
Aged
31
2018
9058
0.650
Why?
Carcinoma
3
2016
80
0.640
Why?
Treatment Outcome
22
2018
3397
0.610
Why?
Male
44
2018
15795
0.600
Why?
Digestive System Surgical Procedures
2
2003
22
0.590
Why?
Educational Measurement
3
2015
63
0.580
Why?
Humans
59
2018
27077
0.580
Why?
Recurrence
10
2017
350
0.570
Why?
Retrospective Studies
25
2018
2843
0.570
Why?
Quality Improvement
4
2014
148
0.550
Why?
Adult
30
2018
8863
0.540
Why?
Hepatectomy
6
2015
59
0.530
Why?
Colonic Neoplasms
3
2016
82
0.530
Why?
Female
42
2018
16186
0.520
Why?
Esophagectomy
5
2002
23
0.510
Why?
Liver Neoplasms
5
2000
118
0.510
Why?
Colectomy
3
2016
33
0.500
Why?
Curriculum
2
2003
133
0.490
Why?
Polytetrafluoroethylene
2
2003
8
0.490
Why?
Pancreatic Neoplasms
5
2013
158
0.430
Why?
Students, Medical
2
2013
41
0.400
Why?
Aged, 80 and over
13
2017
4622
0.380
Why?
Ambulatory Surgical Procedures
3
2007
75
0.360
Why?
Risk Factors
9
2018
2333
0.360
Why?
Prospective Studies
9
2014
1609
0.350
Why?
Survival Rate
9
2015
425
0.340
Why?
Smoking
2
2016
173
0.330
Why?
Hernia, Hiatal
2
2014
14
0.310
Why?
Polypropylenes
1
2003
2
0.290
Why?
Gastrectomy
3
2015
22
0.290
Why?
Cholangiography
4
2015
12
0.270
Why?
Pancreaticoduodenectomy
3
2013
36
0.270
Why?
Follow-Up Studies
7
2017
1887
0.270
Why?
Prognosis
6
2017
935
0.270
Why?
Colorectal Neoplasms
4
1997
107
0.260
Why?
Hernia, Femoral
1
2001
1
0.250
Why?
Transforming Growth Factor alpha
1
2000
7
0.240
Why?
Lymphokines
1
2000
13
0.240
Why?
Endothelial Growth Factors
1
2000
8
0.240
Why?
Peritoneum
2
2003
16
0.230
Why?
Elective Surgical Procedures
2
2017
48
0.230
Why?
United States
9
2016
2140
0.230
Why?
Neovascularization, Pathologic
1
2000
65
0.230
Why?
Suture Techniques
3
2007
128
0.220
Why?
Adolescent
6
2007
2394
0.210
Why?
Pneumonia
2
2016
76
0.210
Why?
Carcinoma, Squamous Cell
2
1997
188
0.210
Why?
Intra-Abdominal Hypertension
1
2018
2
0.210
Why?
Compartment Syndromes
1
2018
10
0.210
Why?
Cholelithiasis
1
1998
10
0.210
Why?
Gallstones
1
1998
11
0.210
Why?
Cholecystectomy
3
2013
16
0.210
Why?
Internship and Residency
3
2015
155
0.200
Why?
Surgical Wound Infection
3
2016
99
0.200
Why?
Lipoma
1
2017
7
0.200
Why?
Myoepithelioma
1
2017
4
0.200
Why?
Trachea
1
1997
18
0.200
Why?
Survival Analysis
6
2015
377
0.190
Why?
Soft Tissue Neoplasms
1
2017
33
0.190
Why?
Liver
2
1997
204
0.190
Why?
Databases, Factual
5
2016
323
0.190
Why?
Mesenteric Vascular Occlusion
1
1996
4
0.190
Why?
Analysis of Variance
3
2003
364
0.180
Why?
Cytoreduction Surgical Procedures
1
2016
7
0.180
Why?
Enterostomy
1
2016
6
0.180
Why?
Portal Vein
1
1996
44
0.170
Why?
Prostheses and Implants
1
1997
165
0.170
Why?
Radiation Tolerance
1
1995
8
0.170
Why?
Thrombosis
1
1996
63
0.170
Why?
Fundoplication
2
2013
24
0.170
Why?
Retroperitoneal Neoplasms
1
2015
8
0.170
Why?
Organs at Risk
1
2015
16
0.170
Why?
Tumor Burden
1
2015
42
0.170
Why?
Liver Regeneration
1
1995
24
0.170
Why?
Radiation Oncology
1
2015
17
0.170
Why?
Gallbladder Neoplasms
1
2015
7
0.170
Why?
Certification
1
2015
54
0.170
Why?
Esophagus
2
2012
59
0.160
Why?
Appendectomy
1
2014
10
0.160
Why?
Hospital Costs
1
1996
69
0.160
Why?
Appendicitis
1
2014
10
0.160
Why?
Abdominal Neoplasms
1
2014
13
0.160
Why?
Ovarian Neoplasms
1
2016
75
0.160
Why?
Body Mass Index
1
2017
391
0.160
Why?
Safety
2
2007
56
0.160
Why?
Image-Guided Biopsy
1
2014
29
0.160
Why?
Neoplasm Staging
5
2015
483
0.160
Why?
Radiotherapy Planning, Computer-Assisted
1
2015
73
0.160
Why?
Logistic Models
4
2016
459
0.160
Why?
Lymphoma
1
2014
55
0.160
Why?
Clinical Competence
3
2013
251
0.160
Why?
Pain, Postoperative
3
2013
244
0.150
Why?
Biliary Dyskinesia
1
2013
4
0.150
Why?
Cholestasis
1
1993
8
0.150
Why?
Multivariate Analysis
3
2016
371
0.150
Why?
Intestine, Small
1
2014
35
0.150
Why?
Specialties, Surgical
1
2013
5
0.150
Why?
Surgical Procedures, Operative
1
2013
34
0.150
Why?
Gallbladder Diseases
1
2013
6
0.150
Why?
Duodenal Neoplasms
1
2013
10
0.150
Why?
Education, Medical, Undergraduate
1
2013
30
0.150
Why?
Abdominal Wall
1
2013
4
0.140
Why?
Sarcoma
1
2015
93
0.140
Why?
Length of Stay
5
2014
325
0.140
Why?
Operative Time
4
2014
85
0.140
Why?
Neoplasms, Multiple Primary
1
2013
39
0.140
Why?
Patient Satisfaction
2
2013
264
0.140
Why?
Education, Medical, Graduate
1
2013
68
0.140
Why?
Practice Guidelines as Topic
1
2015
349
0.130
Why?
Severity of Illness Index
1
2017
1144
0.130
Why?
Prosthesis Implantation
2
2013
43
0.130
Why?
Sepsis
1
2014
149
0.130
Why?
Stents
1
1993
147
0.130
Why?
Esophageal Achalasia
1
2012
22
0.130
Why?
Kidney
1
2013
190
0.130
Why?
Morbidity
3
2014
65
0.120
Why?
Time Factors
4
2014
1761
0.120
Why?
Lymph Node Excision
2
2015
38
0.120
Why?
Reoperation
5
2016
808
0.110
Why?
Program Evaluation
2
2013
146
0.100
Why?
Hernia, Abdominal
1
2007
2
0.100
Why?
Polyurethanes
1
2007
10
0.100
Why?
Omentum
1
2007
9
0.100
Why?
Chicago
2
2001
841
0.100
Why?
Statistics, Nonparametric
2
2000
157
0.100
Why?
Child
3
2001
1348
0.080
Why?
Age Factors
2
2016
841
0.080
Why?
Sutures
2
2003
41
0.080
Why?
Anastomosis, Surgical
2
2016
55
0.080
Why?
Sensitivity and Specificity
3
2007
583
0.080
Why?
Algorithms
2
2015
389
0.080
Why?
Longitudinal Studies
1
2007
1237
0.070
Why?
Tomography, X-Ray Computed
4
2015
829
0.070
Why?
Comorbidity
2
2016
497
0.070
Why?
Minimally Invasive Surgical Procedures
2
2014
266
0.070
Why?
Vascular Diseases
1
2002
43
0.070
Why?
Disease-Free Survival
2
2000
230
0.070
Why?
Probability
1
2002
96
0.070
Why?
Confidence Intervals
1
2002
104
0.070
Why?
Ultrasonography
3
1997
187
0.060
Why?
Models, Educational
1
2001
38
0.060
Why?
Workload
1
2001
36
0.060
Why?
Vascular Endothelial Growth Factors
1
2000
10
0.060
Why?
von Willebrand Factor
1
2000
11
0.060
Why?
Intraoperative Care
2
1998
56
0.060
Why?
Barrett Esophagus
1
2000
19
0.060
Why?
Vascular Endothelial Growth Factor A
1
2000
59
0.060
Why?
Lymphatic Metastasis
1
2000
99
0.060
Why?
Risk Assessment
2
2017
727
0.060
Why?
Endosonography
1
1999
14
0.060
Why?
Infant
1
2001
598
0.060
Why?
Adenocarcinoma, Papillary
1
1999
2
0.050
Why?
Child, Preschool
1
2001
730
0.050
Why?
Neoplasm Recurrence, Local
1
2000
182
0.050
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
1998
9
0.050
Why?
Liver Function Tests
1
1998
29
0.050
Why?
Patient Selection
1
2000
241
0.050
Why?
Bronchial Neoplasms
1
1997
14
0.050
Why?
Groin
1
2017
6
0.050
Why?
Thigh
1
2017
34
0.050
Why?
Incidental Findings
1
2017
18
0.050
Why?
Pilot Projects
2
1997
394
0.050
Why?
Combined Modality Therapy
2
1997
456
0.050
Why?
Neoplasm Invasiveness
1
1997
100
0.050
Why?
Radiotherapy, Adjuvant
1
2017
86
0.050
Why?
Cryosurgery
1
1997
16
0.050
Why?
Diagnosis, Differential
2
2014
447
0.050
Why?
Intestinal Polyps
1
1996
1
0.050
Why?
Mesenteric Veins
1
1996
1
0.050
Why?
Sigmoid Neoplasms
1
1996
1
0.050
Why?
Biopsy, Needle
1
2017
115
0.050
Why?
Angina Pectoris
1
2016
18
0.050
Why?
Peripheral Vascular Diseases
1
2016
13
0.050
Why?
Rectal Neoplasms
1
1996
26
0.050
Why?
Pulmonary Disease, Chronic Obstructive
1
2016
35
0.040
Why?
Predictive Value of Tests
1
1998
592
0.040
Why?
Cost Savings
1
1996
34
0.040
Why?
Immunohistochemistry
1
2017
487
0.040
Why?
Liver Neoplasms, Experimental
1
1995
1
0.040
Why?
Bilirubin
1
1995
13
0.040
Why?
Cardia
1
1995
3
0.040
Why?
Diabetes Mellitus
1
2016
105
0.040
Why?
Aspartate Aminotransferases
1
1995
19
0.040
Why?
Cost-Benefit Analysis
1
1996
130
0.040
Why?
Alanine Transaminase
1
1995
23
0.040
Why?
Intestines
1
2016
99
0.040
Why?
Random Allocation
1
1995
157
0.040
Why?
Neoplasm Metastasis
1
1995
141
0.040
Why?
Observer Variation
1
2015
131
0.040
Why?
Consensus
1
2015
61
0.040
Why?
Ultrasonography, Interventional
1
2015
64
0.040
Why?
Jejunum
1
1994
14
0.040
Why?
Surgical Stapling
1
1994
9
0.040
Why?
Hypertension
1
2016
217
0.040
Why?
Sex Factors
1
2016
483
0.040
Why?
Hospitals, University
1
1994
45
0.040
Why?
Digestive System Neoplasms
1
1993
6
0.040
Why?
Illinois
1
2014
221
0.040
Why?
Attitude of Health Personnel
1
2015
167
0.040
Why?
Radiography
1
1996
702
0.040
Why?
Blood Transfusion
1
2014
63
0.040
Why?
Rats, Sprague-Dawley
1
1995
476
0.040
Why?
Hospital Mortality
1
2015
148
0.040
Why?
Ileus
1
2013
4
0.040
Why?
Seroma
1
2013
4
0.040
Why?
Product Surveillance, Postmarketing
1
2013
17
0.040
Why?
Lumbar Vertebrae
1
1999
405
0.040
Why?
Wound Healing
1
2014
164
0.040
Why?
Spinal Fusion
1
1999
374
0.040
Why?
Rats
1
1995
927
0.030
Why?
Device Removal
1
2013
97
0.030
Why?
Intraoperative Period
3
1997
39
0.030
Why?
Disease Models, Animal
1
1995
761
0.030
Why?
Case-Control Studies
1
2013
625
0.030
Why?
Cohort Studies
1
2015
1704
0.030
Why?
Quality of Life
1
2013
529
0.030
Why?
Surgical Instruments
1
2007
20
0.020
Why?
Ischemia
1
2007
27
0.020
Why?
Blood Loss, Surgical
2
1999
64
0.020
Why?
Laparotomy
2
1997
21
0.020
Why?
Animals
1
1995
4896
0.020
Why?
Prosthesis Design
1
2007
449
0.020
Why?
Pancreatitis
1
2002
27
0.020
Why?
Medical Records
1
2002
39
0.020
Why?
Chronic Disease
1
2002
485
0.010
Why?
Cystadenocarcinoma
1
1999
1
0.010
Why?
Cystadenoma
1
1999
1
0.010
Why?
Retroperitoneal Space
1
1999
14
0.010
Why?
Orthopedic Fixation Devices
1
1999
24
0.010
Why?
Fluorouracil
1
1997
88
0.010
Why?
Radiotherapy Dosage
1
1997
145
0.010
Why?
Cisplatin
1
1997
106
0.010
Why?
Feasibility Studies
1
1997
222
0.010
Why?
Anastomosis, Roux-en-Y
1
1994
7
0.010
Why?
Esophagogastric Junction
1
1994
13
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1997
381
0.010
Why?
Puerto Rico
1
1993
15
0.010
Why?
Bile Ducts
1
1993
10
0.010
Why?
Data Collection
1
1993
117
0.010
Why?
Intraoperative Complications
1
1993
72
0.010
Why?
Magnetic Resonance Imaging
1
1997
1128
0.010
Why?
Millikan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description